Abstract A valid method of studying age related degenerative pathologies is to study human genetic diseases that appear to accelerate many, though not necessarily all, features of the aging process. Such diseases are described as progeroid syndromes because of their possible relevance to many aspects of aging and age related disease. This article describes the recent progress made at the cellular and molecular levels in understanding the pathogenesis of one of the best characterised of these disorders, Werner's syndrome. These observations are related to some of the less well characterised progeroid syndromes within the context of the cell senescence hypothesis of aging, a theory formulated to explain the aging of regenerative tissue in normal individuals.
With the proportion of the elderly within the population increasing dramatically the effects of the aging process are already the major item of expenditure for the National Health Service and will become the major health care challenge of the next century.' Aging is associated with a subset of diseases including potentially fatal cardiovascular disorders, diabetes, and neoplasms, and crippling conditions such as cataract, macular degeneration, and auditory impairment, which greatly reduce the quality of later life. Understanding the mechanisms of human aging may therefore give important insights into the pathogenesis of a range of age related diseases. It may also allow age related diseases to be attacked at their roots by disabling the aging process itself, such a preventive approach being attractive for more than simple economic reasons.
Human aging, distal and proximal causes, and model systems "Why do we die of old age?" is perhaps the most fundamental physiological question it is possible to ask. Before any discussion of this process is undertaken it is helpful to distinguish the separate questions of "why do we age?" and "how do we age?". To the question of why perhaps the most persuasive argument is that offered by the disposable soma theory of Kirkwood and Holliday' that explains aging as the inevitable result of the optimisation of evolutionary fitness in animal populations. In this model, aging occurs because insufficient physiological resources are allocated by the body to somatic repair and maintenance. This model thus rules out a central "clock" that controls the process. Such a central programme would require resources to operate and this very process would compromise reproductive efficiency. It should however be emphasised that the lack of a mechanistic aging programme does not indicate the lack of involvement of programmed mechanisms in aging (such as development or tissue repair). Indeed, one such mechanism, the senescence of individual human cells, has been proposed as a key process in the age related failure of regenerative tissue3 and will be discussed in detail later.
As an evolutionary side effect of millions of years of selection for reproductive success the genetic basis of aging is potentially extremely broad. Estimates of the number of genes that may have a role in determining lifespan in Homo sapiens have ranged from several hundred to tens of thousands (upwards of 7% of the total human genome4). With such a highly polygenic system, to suggest that any single mechanism or simple network of mechanisms is responsible for the aging of a whole organism is rather naive. Applying the same logic the identification of candidate genes involved in successful aging through the study of normal centenarian "survivor" populations, while potentially feasible is likely to prove an extremely complicated task.5 6 An alternative approach, first articulated as a formal concept by George Martin, is the study of heritable genetic diseases that mimic some, but not all, the features of the aging process, to gain insights into how the aging process functions in normal individuals. The study of such progeroid syndromes (like premature senility) has the advantage that only a single gene is usually involved in each case. This renders hypotheses easier to frame and test and makes the potential identification of the defective allele amenable to modern reverse genetics and gene mapping studies in a way that the study of polygenic traits is not. The disadvantage of studying progeroid syndromes is that they are essentially phenocopies of normal aging rather than the genuine article, any observations must thus be evaluated within the context of theories designed to explain how normal aging operates. One such theory is the cell hypothesis of aging.
Cell hypothesis of aging A priori the simplest question that can be asked regarding the operation of the aging process is whether the mechanism of aging functions at the level of the organism or of the cells that compose it. For the first half of this century it was generally believed, based on experiments conducted in the laboratory of the Nobel laureate Alexis Carrel,7 that individual cells were immortal once placed into culture and that the mechanism of the aging process thus represented a failure of the organisation rather than the component parts. However, in the 1960s a series of experiments by Hayflick and Moorehead8 demonstrated that normal human fibroblasts would only proliferate for a fixed number of passages during which the population would double in number about 50 times. The number of "population doublings" a culture would undergo appeared to be fixed by a mechanism internal to the cells that composed it. This theory was based on experiments in which cells from populations with different growth abilities were cocultivated and on the observation that cryopreservation in liquid nitrogen did not cause the culture to "forget how old it was"."' After completing its quota of population doublings the culture would be entirely composed of cells in a non-dividing state, which Hayflick termed "senescence". Based in part on the observation that embryonic fibroblasts completed more population doublings than neonatal cells, Hayflick proposed that senescence was linked to the aging process. These observations have been confirmed by hundreds of reports involving every renewing or conditionally renewing normal mammalian cell type that has been subjected to rigorous investigation. In addition a number of observations has emerged that support Hayflick's original contention that cell senescence and aging are associated ( This behaviour and related work based on the analysis of clone sizes through the life spans of human fibroblast" and glial cell'8 cultures is consistent with a counting mechanism that group.bmj.com on July 1, 2017 -Published by http://mp.bmj.com/ Downloaded from that senescent nuclei or cytoplasm could inhibit DNA synthesis in the young nucleus32; (3) that synkaryon fusions of immortalised cells gave rise to clones that underwent senescence, and that the fusion partners in these studies could be assigned into four distinct complementation groups. 33 The principal molecule involved in bringing about senescence in fibroblasts appears to be the p21 inhibitor of the cdk2-cyclin complexes.3 p21 was originally identified as a cell senescence derived inhibitor in an expression screen. 34 Recently evidence has also emerged that the p 16 INK4 inhibitor may also repress cdk4-cyclin D kinase activity. 35 36 Both cyclin D kinase inhibitors and their upstream regulatory genes, such as p53, are involved in a wide range of cell death and differentiation processes.37 However, cell senescence is not an apoptotic phenomenon and has recently been shown to be a distinct process from terminal differentiation.38 These molecules appear to be the effectors of cell senescence rather than the trigger, which must be sought at a higher level of cell control.
One of the most plausible systems by which cells may count their divisions to have been suggested in recent years is the progressive loss of telomeric sequences from the ends of chromosomes. In the absence of any mechanism to produce compensatory de novo synthesis of telomeric DNA, these chromosomes are faced with what has been termed the "end replication problem".39 This results from the inability of all known DNA dependent DNA polymerases to commence synthesis de novo. At the termini a region at least as large as the priming RNA primer for lagging strand DNA synthesis will systematically be deleted every time the cell undergoes division. In contrast, in most immortal human cell lines there appears to be compensatory de novo synthesis of telomeric DNA by the enzyme telomerase and a stable maintenance of telomere length.39""
In most primary human cells telomerase is absent, and telomere shortening with proliferation in vitro has been reported.4"'3 This shortening is presumed to reflect losses from a failure in end replication, although the problem of C strand degradation may also be shown to contribute." An analogous decline in telomere length with donor age has been reported for a variety of human tissues.40 45 As the loss of telomeric DNA is linked to passage through S phase it forms an attractive mechanism by which cells can count divisions. However, as all the components of the telomerase enzyme have yet to be cloned, interventional tests of the hypothesis are not yet possible.
Why does senescence matter? Once senescent, human cells display a variety of characteristics that are best broadly described as a cessation of DNA replication under normal conditions, and an altered spectrum of gene expression. This is best illustrated in adherent cells where a dramatic shift in cell size usually also accompanies the onset of senescence (fig 2) . It should be noted that senescence is a highly active but selective process, some genes are repressed, some genes are upregulated, and some totally novel messages are induced. This is perhaps best illustrated with respect to the c-fos proto-oncogene. Repression of c-fos is a characteristic event in the replicative failure of T cells46 and fibroblasts47 (although it does not occur in senescent melanocytes3). However, a number of other cell cycle associated genes (including c-myc and H-ras) are not repressed.48 Table 2 lists a number of the principal changes identified in senescent cells. Many more have been reported. 49 J! Figure 2 Haematoxylin and eosin staining of (top) young and (bottom) sen mesothelial cells (original magnification x400).
Linking celi senescence and progeroid syndromes Given the contention that cell senescence is linked to the normal aging process the ability of cells from progeroid donors to grow in culture has been studied for over 30 years. These studies have principally involved the segmental progeroid syndromes (that subset of progeroid syndromes in which multiple aspects of aging are The discovery that WRN is a mutant helicase associated with a mutator phenotype potentially strengthens the association. However, defective DNA repair has not been unequivocally observed in Werner's syndrome either in studies using classic DNA repair assays such as unscheduled DNA synthesis80 and mutagen survival studies,8" or more sophisticated assays for strand specific or gene specific repair.82
Similarly, cells from donors with classic DNA repair defects such as xerderma pigmentosum do not show accelerated senescence, although a mutator phenotype is present in at least some complementation groups.83 Instead a defective ability to repair ultraviolet damage products is present. Cockayne's syndrome, a highly placed candidate for a segmental progeroid syndrome, has three distinct complementation groups, one of which (group B) is due to a defective helicase (ERCC6).84 In this syndrome excision repair of ultraviolet damage is essentially normal but the cells show a failure of RNA synthesis recovery following ultraviolet exposure.85 To complicate matters further overlapping xerderma pigmentosum and Cockayne's syndrome phenotypes exist86; and while some Cockayne's syndrome fibroblast strains show a slightly reduced lifespan in vitro the number of population doublings achieved are very close to the normal range, unlike Werner's syndrome in which there is no overlap. Similarly some ataxia telangiectasia fibroblasts demonstrate a reduced lifespan in culture but the syndrome has at least nine recognisable complementation groups rendering analysis complex. Cells from trichothiodystrophy, a disorder with two complementation groups one of which shows DNA repair defects, has never been reported to show accelerated cell senescence.84 Hutchinson-Gilford progeria, perhaps the best known of all progeroid syndromes, is associated with severely reduced fibroblast growth in vitro; however, its DNA repair features are variable, which suggests that different complementation groups may also exist within the disease.6" It is clear that any relation between aging and DNA damage will not be a simple affair and will require rigorous study to validate.
Is senescence the result of altered telomere metabolism? Do any of these premature aging syndromes shed light on the normal process of aging, and in particular do any critically address the normal mechanism leading to replicative senescence? One of the more plausible models for the trigger to replicative senescence is that progressive telomere shortening in somatic cells that do not express telomerase eventually leads to one Another caveat regarding the data on telomere loss rates in Werner's syndrome cells is that the hypothesised most important biological variable is not the average telomere length, but rather that of the shortest telomere in the nucleus. It is possible, therefore, that the distribution of telomere lengths might be altered in Werner's syndrome cells (because of alterations in telomere metabolism), leading to a situation where bulk telomere length is somewhat larger than normal when the first critically short telomere arises. This is a possibility that requires further attention as there clearly is some form of alteration in telomere dynamics in Werner's syndrome cells (the rate of loss is greater than in normal cells).
How might this arise? It seems at first paradoxical that telomere loss rates could vary between cells that express no detectable telomerase activity. Certainly there will be a basal level of telomere loss because of the end replication problem, but there is increasing data for an additional route to telomere shortening involving degradation of the C-strand of the telomere, the strand complementary to that synthesised by telomerase. This stems from studies in budding yeast where certain cdc13
and stnm alleles on the appropriate genetic background led to the accumulation of extensive regions of single stranded DNA extending from the end of the chromosome, reflecting degradation of the C-strand in a cell cycle controlled fashion... [95] [96] [97] [98] Mutations in RAD24 can suppress this phenotype-of interest as the product of this gene regulates the activity of RAD17, an exonuclease whose known directionality (3-<5) is just that necessary to produce C-strand degradation from the telomere.99 This model illustrates the potential to modulate telomere loss rates independent of telomerase. Although mammalian homologues of CDC 13 and others have yet to be identified, a structural analysis of human telomeres is consistent with the existence of a C-strand degradation pathway in human cells.'°°It is interesting to note that human fibroblasts grown in 40% partial pressure of oxygen show a marked increase in both the rate of senescence and of telomere loss, together with an accumulation of single stranded DNA at the telomeres.10' Although consistent with the available data, whether hyperoxia exerts its effects by modulating C-strand degradation remains to be determined.
The mechanism whereby senescence is activated in Werner's syndrome cells remains a mystery. The altered telomere dynamics92 suggest some altered behaviour in these regions, but whether this is causal in the premature senescent phenotype, or whether it is simply a side effect of a mutation potentially capable of modulating DNA and chromatin structure, is far from clear. It is important to note that the mechanism whereby senescence is activated in Werner's syndrome cells is not necessarily the same as that normally used by fibroblasts at the end of their lifespan, as the cell senescence hypothesis of aging is concerned with the occurrence and phenotype of senescent cells rather than the details of the mechanism that led to them arising. Indeed, the ability of H-rasV12, hyperoxia, and histone deactelyase inhibitors9 94 101 all to trigger apparently indistinguishable states of cellular senescence seems to indicate that multiple effectors can lead to the same final outcome. With so many potential triggers there is ample room for genetic lesions such as WRN to lead to senescent cells by activating an alternative route, as opposed to modulating the normal effector route to senescence. Perhaps the characterisation of other progeroid syndromes to the level of detail now available for Werner's syndrome will shed additional light on the control of these processes and ultimately on aging itself.
